Contact Us Global About Amicus Amicus Therapeutics (Nasdaq:FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living with rare metabolic diseases. Message from the Chairman and CEO We are a global biotechnology company at the forefront of advancing therapies for a range of rare and devastating diseases and our excellent team has a very big and a very bold vision. Each program that we invest in has to have three key characteristics. It has to be in the rare diseases for a devastating disorder, the technology has to have the potential to be first in class or best in class, and the clinical data must be able to provide meaningful benefit for patients. As we pursue treatments for rare metabolic disorders, we maintain a personal and compassionate focus on patients, their caregivers, and families. This personal and direct relationship with patients embodies the culture of our organization and drives what we do very passionately every day. Every biotech company says it’s focused on patients, but at Amicus we do it in a different way. You see it when you go to our offices around the world where we have pictures of patients with the diseases we treat accompanied by narratives about their struggles, identities, and lives. How do we take that perspective and build it into every part of the business? All the way from team meetings to the board of directors, we try to make all our decisions as if we were living with these diseases or were a mom or dad or kid caring for someone with this disorder. What would be important to me as a patient? What would be a meaningful advancement or a risk I would take? We do more than say that we are patient focused – we live it. That dedication to patients goes hand-in-hand with our dedication to ethics and compliance. You can’t have one without the other. Acting with integrity and complying with law ensures that everything we do for patients meets the highest standards of safety and professionalism. What I am most proud of at Amicus is the resilience and persistence of our team. The ability to look to the future for our vision of what we want the company to be then engage in a journey of learning, adjustment, and focus takes a special type of person. My role is to set the vision and make sure that day to day it is achieved through extraordinary science, aligning priorities, and hiring the greatest people in the world to be here. Our passion unites us as we remain committed to helping those in need. All the best, John F. Crowley Chairman and CEO Amicus Founding Beliefs In 2005, the employees of Amicus crafted a belief statement that would encompass our core values and remind us of the reason we do what we do every day. These highly valued statements outline the fundamental beliefs that are crucial to understanding the passion and commitment behind Amicus. The statements below offer a set of standards that employees are proud to stand by, showcasing our bold nature and driven personalities. We Believe… In the Fight to Remain at the Forefront of Therapies for Rare and Orphan Diseases We seek to deliver the highest quality therapies for persons living with these diseases We support the disease communities – and their families We are passionate about what we do We encourage and embrace constant innovation We have a duty to obsolete our own technologies We push ideas as far and as fast as possible We take smart risks We work hard We keep asking the tough questions We will never be constrained by prior thinking We learn from our mistakes We think differently – very differently We Believe… In Our Future to Build Long-term Value for Our Stakeholders We Believe… In Each Other to Foster Teamwork and Respect for Each Individual’s Contribution Join our Team View Open Positions Featured Positions Director, Managed Markets and Trade The Director, Managed Markets and Trade is responsible for gaining and maintaining broad coverage/access for Amicus promoted products within private and public payer segment. This is a field based position. The DMM will be responsible for creating, implementing and executing account business plans that serve as a road map for strategic and tactical plan execution. Additionally, the DMM is responsible for managing Specialty Pharmacy Provider account(s) as assigned. Rare Stories Be inspired by people living with rare diseases across the globe. Natalie, Age 31 Living with Fabry Disease Vicki & Adriana, Ages 43 & 18 Living with Fabry Disease Kiera, Age 14 Living with CDKL5 Deficiency Disorder (CDD) About Amicus Chairman’s Welcome Leadership Belief Statement Contact Us Message from BIO Patient Advocacy Disease Information Rare Stories Patient Advisory Boards Corporate Giving Resources Expanded Access Programs & Pipeline Pipeline Our Programs Clinical Trials Product Overview Amicus Assist™ Responsibility Ethics & Compliance Global Medical Affairs Corporate Giving Healing Beyond Disease ESG Report Investors & Media Corporate Governance Press Releases Events & Presentations Annual Reports & Proxies SEC Filings Stock Performance Investor FAQs Featured Coverage Careers Overview Who We Are Search Social Media Twitter YouTube LinkedIn Copyright © 2021 Amicus Therapeutics, Inc. All rights reserved. NP-AT-ALL-00011119 Cookies Statement Terms of Use Privacy Notice Amicus Therapeutics informs you that our website uses its own and third party cookies to improve our services and collect statistical information about your browsing. By clicking accept, we consider that you accept its use. For more information, or to know how to change the configuration, consult our Privacy Policy. Accept